Key House Democrat demands NIH answer for pace of long Covid research
A powerful Democratic lawmaker is interrogating the National Institutes of Health over its slow progress in addressing long Covid, citing a recent STAT investigation.
WASHINGTON — A powerful Democratic lawmaker is interrogating the National Institutes of Health over its slow progress in addressing long Covid, citing a recent STAT investigation into the agency’s lack of urgency.
Rep. Anna Eshoo, the House Energy and Commerce health subcommittee’s top Democrat, sent a letter to NIH acting Director Lawrence Tabak on Tuesday highlighting the agency’s delays in enrolling clinical trials, the lack of relief for patients, and the exclusion of long Covid from the White House’s Next Gen program to accelerate development of Covid-19 vaccines and treatments. The Energy and Commerce Committee is responsible for overseeing the NIH.
What's Your Reaction?
